Tchaikapharma High Quality Medicines AD Logo

Tchaikapharma High Quality Medicines AD

THQM | BSOBGN

Overview

Corporate Details

ISIN(s):
BG1100008074
LEI:
5299003VDHTK75D1JE38
Country:
Bulgaria
Address:
бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Tchaikapharma High Quality Medicines Inc. is the fastest growing pharmaceutical manufacturer operating in Bulgaria. The company is focused on making available contemporary therapeutical solutions on the local, regional and European market in accordance with Good Manufacturing Practice (GMP). Our expertise in fast market penetration is proven by the results we have achieved and continue to achieve for our partners. Our success is built on true respect for the patient and a lasting bond with physicians. Pursuant to its core strategic objectives of transparency and growth, Tchaikapharma goes public in 2015. The company’s shares have been traded successfully on the Bulgarian Stock Exchange since then.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-04-15 23:00
Annual Audited Financial Statements
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
English 47.8 KB
2024-04-15 23:00
Regulatory News Service
609557-7TH_2023 CONS_BG_signed.xls
Bulgarian 719.5 KB
2024-04-15 23:00
Regulatory News Service
609559-7TH_2023 CONS_EN_signed.xls
Bulgarian 235.0 KB
2024-04-15 23:00
Regulatory News Service
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
Bulgarian 6.4 MB
2024-03-26 23:00
Regulatory News Service
608037-SPRAVKA_1_IND_GFO_6M.xls
Bulgarian 722.0 KB
2024-03-26 23:00
Regulatory News Service
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
Bulgarian 21.8 MB
2023-07-12 23:00
Regulatory News Service
7TH_2022 CONS_BG.xls
Bulgarian 718.0 KB
2023-06-07 23:00
Regulatory News Service
SPRAVKA_1_IND_GFO_6M_signed.xls
Bulgarian 778.5 KB
2023-06-07 23:00
Regulatory News Service
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
Bulgarian 37.0 MB
2022-07-26 23:00
Regulatory News Service
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
Bulgarian 5.7 MB
2022-07-26 23:00
Regulatory News Service
7TH_2021_signed.xls
Bulgarian 939.0 KB
2022-07-26 23:00
Regulatory News Service
5299003VDHTK75D1JE38-20211231-BG-CON.zip
Bulgarian 3.2 MB
2022-07-26 23:00
Regulatory News Service
7TH_2021 CONS.xls
Bulgarian 900.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Rekah Pharmaceutical Prod Ltd. Logo Rekah Pharmaceutical Prod Ltd. Israel REKA
RELIEF Therapeutics Holding AG Logo RELIEF Therapeutics Holding AG Switzerland RLF
Replek AD Logo Replek AD North Macedonia REPL
Roche Holding AG Logo Roche Holding AG Switzerland RO
Ropharma S.A. Logo Ropharma S.A. Romania RPH
RYVU Therapeutics S.A. Logo RYVU Therapeutics S.A. Poland RVU
Sano Bruno's Enterprises Ltd. Logo Sano Bruno's Enterprises Ltd. Israel SANO1
Sanofi Logo Sanofi France SAN
Santhera Pharmaceuticals Holding AG Logo Santhera Pharmaceuticals Holding AG Switzerland SANN
Schott Pharma Logo Schott Pharma Germany 1SXP